Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock（LIMN）股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · LIMN · 截至 Jun 8, 2026
关键指标
探索 Liminatus Pharma, Inc. Class A Common Stock 数据
limn stock data · financials财务快照
完整财报竞争对手与同行
limn competitorsLIMN
ATHE
BTAI
DYAI
EVAX
GBIO股票表现
完整历史关于 Liminatus Pharma, Inc. Class A Common Stock
Liminatus Pharma, Inc. Class A Common Stock Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, C…
what is liminatus pharma, inc. class a common stock · limn stock overview · liminatus pharma, inc. class a common stock company profile · who is liminatus pharma, inc. class a common stock ceo · limn NASDAQ · liminatus pharma, inc. class a common stock headquarters · liminatus pharma, inc. class a common stock business segments
关于股票概览与关键数据
Liminatus Pharma, Inc. Class A Common Stock（LIMN）是 Biotechnology 行业的 Healthcare 类公司，于 May 1, 2025 在 NASDAQ 上市。截至最近交易日，LIMN 股价为 $0.14，市值约为 $3.8M。过去12个月累计回报 -99.46%，年初至今回报 -76.89%。
2025 财年 Liminatus Pharma, Inc. Class A Common Stock 营收 —。完整财务数据（营收历史、盈利、资产负债表）请使用上方标签页。
常见问题
截至最近一个交易日，Liminatus Pharma, Inc. Class A Common Stock（LIMN）股价为 $0.14，在 NASDAQ 上市，52周区间为 $0.13 – $33.66。